Majority of patients with colorectal cancer do not experience social difficulties
the ONA take:
Although the majority observe no difficulties, a portion of individuals diagnosed with colorectal cancer (CRC) do experience poor social outcomes.
Researchers based at the Leeds Institute of Cancer and Pathology, University of Leeds, St. James's University Hospital, United Kingdom, sent questionnaires to all 12- to 36-month CRC survivors diagnosed in 2010 or 2011 and treated by the English National Health Service. The questionnaire assessed clinical data, sociodemographic information, and included the Social Difficulties Inventory.
The latter inventory is a 16-item scale of social distress that reviews everyday living conditions, self and others subscales, and related items.
Approximately 82% of the 21,802 respondents completed all social distress items. (Overall response rate of the 34,467 individuals contacted was 63.3%.)
Approximately 15% OF individuals reported experiencing social distress. Multivariable analysis indicated that having three or more long-term conditions was a strong precursor to social distress.
It was determined that the majority of individuals diagnosed with CRC experience no social distress, and that the risk factors (clinical and otherwise) can be used to target support for those who are more likely to experience social difficulties.
Although the majority observe no difficulties, a portion of individuals diagnosed with colorectal cancer do experience poor social outcomes.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|